165 related articles for article (PubMed ID: 25496911)
1. Cell penetrating peptide TAT can kill cancer cells via membrane disruption after attachment of camptothecin.
Song J; Zhang Y; Zhang W; Chen J; Yang X; Ma P; Zhang B; Liu B; Ni J; Wang R
Peptides; 2015 Jan; 63():143-9. PubMed ID: 25496911
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
Kanazawa T; Morisaki K; Suzuki S; Takashima Y
Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
[TBL] [Abstract][Full Text] [Related]
3. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate.
Lin CW; Kuo JH; Jan MS
J Drug Target; 2012 Jul; 20(6):515-23. PubMed ID: 22632162
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Antiproliferative Activities of Conjugates of Paclitaxel and Camptothecin with a Cyclic Cell-Penetrating Peptide.
El-Sayed NS; Shirazi AN; Sajid MI; Park SE; Parang K; Tiwari RK
Molecules; 2019 Apr; 24(7):. PubMed ID: 30978971
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
6. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
7. TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy.
Hao X; Yan Q; Zhao J; Wang W; Huang Y; Chen Y
PLoS One; 2015; 10(9):e0138911. PubMed ID: 26405806
[TBL] [Abstract][Full Text] [Related]
8. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide.
Meerovich I; Muthukrishnan N; Johnson GA; Erazo-Oliveras A; Pellois JP
Biochim Biophys Acta; 2014 Jan; 1840(1):507-15. PubMed ID: 24135456
[TBL] [Abstract][Full Text] [Related]
9. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.
Yu GR; Qin WW; Li JP; Hua W; Meng YL; Chen R; Yan B; Wang L; Zhang X; Jia LT; Zhao J; Zhang R; Yang AG
Biosci Rep; 2012 Jun; 32(3):271-9. PubMed ID: 21679157
[TBL] [Abstract][Full Text] [Related]
10. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells.
Zhang W; Song J; Zhang B; Liu L; Wang K; Wang R
Bioconjug Chem; 2011 Jul; 22(7):1410-5. PubMed ID: 21663318
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides induce apoptosis and necrosis through specific mechanism and cause impairment of Na
Qiu Y; Yu Q; Shi K; Zhang M; Zhou X; Yang Y; Liu Y; Tang J; Wang X; He Q
Amino Acids; 2017 Jan; 49(1):75-88. PubMed ID: 27645217
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.
Dharap SS; Qiu B; Williams GC; Sinko P; Stein S; Minko T
J Control Release; 2003 Aug; 91(1-2):61-73. PubMed ID: 12932638
[TBL] [Abstract][Full Text] [Related]
15. Dysoxylum binectariferum bark as a new source of anticancer drug camptothecin: bioactivity-guided isolation and LCMS-based quantification.
Jain SK; Meena S; Gupta AP; Kushwaha M; Uma Shaanker R; Jaglan S; Bharate SB; Vishwakarma RA
Bioorg Med Chem Lett; 2014 Jul; 24(14):3146-9. PubMed ID: 24878199
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery.
Meng L; Huang W; Wang D; Huang X; Zhu X; Yan D
Biomacromolecules; 2013 Aug; 14(8):2601-10. PubMed ID: 23819825
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells.
Moody TW; Fuselier J; Coy DH; Mantey S; Pradhan T; Nakagawa T; Jensen RT
Peptides; 2005 Sep; 26(9):1560-6. PubMed ID: 16112393
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-1 induces cleavage of exogenous alphaB-crystallin transduced by a cell-penetrating peptide.
Yang SW; Lee SM; Choi EY; Lee KH; Kim SH; Shin MJ; Han YS; Kang SM; Chung JH
J Cell Biochem; 2011 Sep; 112(9):2454-62. PubMed ID: 21538481
[TBL] [Abstract][Full Text] [Related]
19. Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.
Liu R; Xi L; Luo D; Ma X; Yang W; Xi Y; Wang H; Qian M; Fan L; Xia X; Li K; Wang D; Zhou J; Meng L; Wang S; Ma D
J Control Release; 2012 Aug; 161(3):893-902. PubMed ID: 22580115
[TBL] [Abstract][Full Text] [Related]
20. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
Duong HH; Yung LY
Int J Pharm; 2013 Sep; 454(1):486-95. PubMed ID: 23792465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
